TriSalus Life Sciences, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2021 | $-205.8K | $-205.8K | — | — |
| Jun 2021 | $-486.2K | $-486.2K | — | — |
| Sep 2021 | $-365.1K | $-365.1K | — | — |
| Dec 2021 | $-680.9K | $-680.9K | — | — |
| Mar 2022 | $-426.0K | $-426.0K | — | — |
| Jun 2022 | $-696.7K | $-696.7K | — | — |
| Sep 2022 | $-22.9M | $-22.9M | — | — |
| Dec 2022 | $-8.3M | $-8.3M | — | — |
| Mar 2023 | $-10.5M | $-10.5M | $7.0K | $74.0K |
| Jun 2023 | $-9.2M | $-9.3M | $31.0K | $68.0K |
| Sep 2023 | $-21.7M | $-21.8M | $178.0K | $260.0K |
| Dec 2023 | $-9.2M | $-9.5M | $372.0K | $1.0M |
| Mar 2024 | $-10.9M | $-10.9M | $66.0K | $1.1M |
| Jun 2024 | $-13.4M | $-13.5M | $60.0K | $1.3M |
| Sep 2024 | $-10.8M | $-11.0M | $169.0K | $1.4M |
| Dec 2024 | $-5.7M | $-5.8M | $50.0K | $1.7M |
| Mar 2025 | $-4.5M | $-5.3M | $754.0K | $1.6M |
| Jun 2025 | $-7.3M | $-7.2M | $-93.0K | $1.9M |
| Sep 2025 | $-3.7M | $-3.9M | $216.0K | $3.4M |
| Dec 2025 | $-2.5M | $-2.5M | $41.0K | $2.2M |
| Mar 2026 | $-6.5M | $-6.6M | $141.0K | $2.5M |
| Jun 2026 | $-10.1M | $-10.2M | $82.0K | $2.6M |